These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28687457)

  • 1. In vitro and in vivo assessment of newer quinoxaline-oxadiazole hybrids as antimicrobial and antiprotozoal agents.
    Patel NB; Patel JN; Purohit AC; Patel VM; Rajani DP; Moo-Puc R; Lopez-Cedillo JC; Nogueda-Torres B; Rivera G
    Int J Antimicrob Agents; 2017 Sep; 50(3):413-418. PubMed ID: 28687457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice.
    dos Santos Filho JM; Moreira DR; de Simone CA; Ferreira RS; McKerrow JH; Meira CS; Guimarães ET; Soares MB
    Bioorg Med Chem; 2012 Nov; 20(21):6423-33. PubMed ID: 23006639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents.
    dos Santos Filho JM; Leite AC; de Oliveira BG; Moreira DR; Lima MS; Soares MB; Leite LF
    Bioorg Med Chem; 2009 Sep; 17(18):6682-91. PubMed ID: 19683450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives.
    Glomb T; Świątek P
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization and biological activity of some new 1,3,4-oxadiazole bearing 2-flouro-4-methoxy phenyl moiety.
    Chandrakantha B; Shetty P; Nambiyar V; Isloor N; Isloor AM
    Eur J Med Chem; 2010 Mar; 45(3):1206-10. PubMed ID: 20004043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and in vitro antimicrobial activities of 5-alkenyl/hydroxyalkenyl-2-phenylamine-1,3,4-oxadiazoles and thiadiazoles.
    Farshori NN; Banday MR; Ahmad A; Khan AU; Rauf A
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1933-8. PubMed ID: 20172722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pyrazoline amidoxime and their 1,2,4-oxadiazole analogues: synthesis and pharmacological screening.
    Ningaiah S; Bhadraiah UK; Keshavamurthy S; Javarasetty C
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4532-9. PubMed ID: 23850201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel quinoxaline 1,4-di-N-oxide derivatives as new potential antichagasic agents.
    Torres E; Moreno-Viguri E; Galiano S; Devarapally G; Crawford PW; Azqueta A; Arbillaga L; Varela J; Birriel E; Di Maio R; Cerecetto H; González M; Aldana I; Monge A; Pérez-Silanes S
    Eur J Med Chem; 2013 Aug; 66():324-34. PubMed ID: 23811257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial studies of 2,4-dichloro-5-fluorophenyl containing oxadiazoles.
    Karthikeyan MS; Prasad DJ; Mahalinga M; Holla BS; Kumari NS
    Eur J Med Chem; 2008 Jan; 43(1):25-31. PubMed ID: 17521777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in design of potential quinoxaline anti-infectives.
    Jampilek J
    Curr Med Chem; 2014; 21(38):4347-73. PubMed ID: 25312209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of novel 1,3,4-oxadiazole derivatives of marine bromopyrrole alkaloids as antimicrobial agent.
    Rane RA; Gutte SD; Sahu NU
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6429-32. PubMed ID: 22967765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.
    Cogo J; Kaplum V; Sangi DP; Ueda-Nakamura T; Corrêa AG; Nakamura CV
    Eur J Med Chem; 2015 Jan; 90():107-23. PubMed ID: 25461316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization and antimicrobial activity of some disubstituted 1,3,4-oxadiazoles carrying 2-(aryloxymethyl)phenyl moiety.
    Naveena CS; Boja P; Kumari NS
    Eur J Med Chem; 2010 Nov; 45(11):4708-19. PubMed ID: 20728250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole derivatives as potent antiproliferative agents via a hybrid pharmacophore approach.
    Kaneko D; Ninomiya M; Yoshikawa R; Ono Y; Sonawane AD; Tanaka K; Nishina A; Koketsu M
    Bioorg Chem; 2020 Nov; 104():104293. PubMed ID: 33010622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of quinoxaline-1,3,4-oxadiazole hybrid derivatives as potent inhibitors of the anti-apoptotic Bcl-2 protein.
    Ono Y; Ninomiya M; Kaneko D; Sonawane AD; Udagawa T; Tanaka K; Nishina A; Koketsu M
    Bioorg Chem; 2020 Nov; 104():104245. PubMed ID: 32911196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, molecular modeling and preliminary biological evaluation of a set of 3-acetyl-2,5-disubstituted-2,3-dihydro-1,3,4-oxadiazole as potential antibacterial, anti-Trypanosoma cruzi and antifungal agents.
    Ishii M; Jorge SD; de Oliveira AA; Palace-Berl F; Sonehara IY; Pasqualoto KF; Tavares LC
    Bioorg Med Chem; 2011 Nov; 19(21):6292-301. PubMed ID: 21962987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Antimicrobial Activity of Some New Substituted Quinoxalines.
    El-Atawy MA; Hamed EA; Alhadi M; Omar AZ
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31752396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antimicrobial studies of a new series of 2-[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]-5-substituted-1,3,4-oxadiazoles.
    Gaonkar SL; Rai KM; Prabhuswamy B
    Eur J Med Chem; 2006 Jul; 41(7):841-6. PubMed ID: 16616395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and molecular docking studies of some new 1,3,4-oxadiazolines bearing 6-methylpyridine moiety for antimicrobial property.
    Shyma PC; Kalluraya B; Peethambar SK; Telkar S; Arulmoli T
    Eur J Med Chem; 2013 Oct; 68():394-404. PubMed ID: 23994867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives.
    Villalobos-Rocha JC; Sánchez-Torres L; Nogueda-Torres B; Segura-Cabrera A; García-Pérez CA; Bocanegra-García V; Palos I; Monge A; Rivera G
    Parasitol Res; 2014 Jun; 113(6):2027-35. PubMed ID: 24691716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.